PET/MRI accurately classifies prostate cancer

PET/MRI can improve diagnostic accuracy for prostate cancer patients and help avoid unnecessary biopsies, according to new research published in the April issue of&nbsp;<em>The Journal of Nuclear Medicine</em>. By applying the PRIMARY scoring system to PET/MRI results, researchers found that more than 80 percent of unnecessary biopsies could be avoided at the expense of missing one in eight clinically significant prostate cancer cases.

Related Keywords

Nanjing ,Jiangsu ,China ,Shan Peng ,Anhui ,Feng Wang ,Hunan ,Yiqing Zhang ,Xuefeng Qiu ,Rebecca Maxey ,Yao Fu ,Jingyan Shi ,Hongqian Guo ,Jiaming Lu ,Twitterand Facebookpages Journalofnucmed ,Mengxia Chen ,Jing Liang ,Danyan Li ,Hospital Of Medical School ,Department Of Urology ,Society Of Nuclear Medicine ,Department Of Pathology ,Center Study ,Hospital Of Nanjing University Medical School ,Journal Of Nuclear Medicine ,Department Of Nuclear Medicine ,Department Of Radiology ,Linkedin ,Prostate Imaging Reporting ,Data System ,Nanjing Drum Tower Hospital ,Affiliated Hospital ,Nanjing University Medical School ,Classifying Patients ,Prospective Single Center ,Medical School ,Nanjing University ,Nuclear Medicine ,Nanjing First Hospital ,Nanjing Medical University ,Twitterand Facebookpages ,Molecular Imaging ,